The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 06, 2011
Filed:
Jul. 14, 2005
Gary Mitchell Karp, Princeton Junction, NJ (US);
Peter Seongwoo Hwang, Edison, NJ (US);
James Takasugi, Lawrenceville, NJ (US);
Hongyu Ren, Dayton, NJ (US);
Richard Gerald Wilde, Somerville, NJ (US);
Anthony Turpoff, Edison, NJ (US);
Alexander Arefolov, Piscataway, NJ (US);
Guangming Chen, Bridgewater, NJ (US);
Jeffrey Allen Campbell, Bethlehem, PA (US);
Christine Espiritu, Highland Park, NJ (US);
Concetta Freund, Staten Island, NY (US);
Zhengxian Gu, Princeton, NJ (US);
Takashi Komatsu, Silver Spring, MD (US);
Gary Mitchell Karp, Princeton Junction, NJ (US);
Peter Seongwoo Hwang, Edison, NJ (US);
James Takasugi, Lawrenceville, NJ (US);
Hongyu Ren, Dayton, NJ (US);
Richard Gerald Wilde, Somerville, NJ (US);
Anthony Turpoff, Edison, NJ (US);
Alexander Arefolov, Piscataway, NJ (US);
Guangming Chen, Bridgewater, NJ (US);
Jeffrey Allen Campbell, Bethlehem, PA (US);
Christine Espiritu, Highland Park, NJ (US);
Concetta Freund, Staten Island, NY (US);
Zhengxian Gu, Princeton, NJ (US);
Takashi Komatsu, Silver Spring, MD (US);
PTC Therapeutics, Inc., South Plainfield, NJ (US);
Abstract
In accordance with the present invention, compounds that inhibit viral replication, preferably Hepatitis C Virus (HCV) replication, have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the treatment or prevention of a viral infection are provided. In another aspect of the invention, compounds useful in the treatment or prevention of HCV infection are provided.